Trevi Therapeutics is developing nalbuphine ER (Haduvio) for chronic cough in IPF and RCC, targeting unmet medical needs.

Oppenheimer carried out rating actions on Nutanix ( NTNX ), Pure Storage ( PSTG) and Rubrik ( RBRK) on Monday. Oppenheimer ...

GPM Investments, a U.S.-based company wholly owned by ARKO (ARKO) has signed a non-binding Memorandum of Understanding (MOU) with Apollo Power, the company said ...

Discover key insights on Symbotic Inc., its growth, risks, and earnings outlook. Click for my look at SYM stock and preview ...

Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...

Though positive on an absolute basis, Diamond Hill International Strategy portfolio modestly trailed the benchmark during the ...

Whitestone REIT has delivered strong recent results and remains undervalued as the market overlooks its ongoing ...

Hims & Hers Health (HIMS) has authorized a share repurchase program of up to $250 million of outstanding Class A common stock over the next three years, the com ...

Tesla's stock demands big AI and self-driving gains to justify its price. Learn why investors should wait for proof before ...

Easterly Government shows solid fundamentals with an 8% yield, Q3 beats, FFO growth, tenant diversification, and strong ...

Discover why Quantum Corp. is gaining investor interest despite struggles in data storage and learn what could drive a ...

Novo Nordisk cuts obesity drug prices to compete with Eli Lilly, offering new patient deals and nationwide access.